Insulin-Induced Copeptin Response in Children and Adolescents to Diagnose Arginine Vasopressin Deficiency
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000541330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Sebastian Gippert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics I, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, German…. Hauptthemen laut MEDLINE: Glycopeptides, Insulin, Arginine Vasopressin, Diabetes Insipidus, Neurogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The diagnosis of arginine vasopressin deficiency (AVD, formerly central diabetes insipidus) remains a challenge. In recent years, stimulated copeptin has emerged as a promising tool to diagnose AVD.
Methods
In this single centre retrospective study, we identified paediatric patients with suspected pituitary insufficiency who underwent standard insulin tolerance testing (ITT) previously. Patients with AVD and non-matched controls without polyuria-polydipsia syndrome were identified. Diagnosis of AVD was confirmed retrospectively using comprehensive clinical and diagnostic characteristics. Serum copeptin concentrations were measured using a commercially available automated immunofluorescence assay (B.R.A.H.M.S Copeptin-proAVP KRYPTOR®) in −20°C stored samples collected before and 30, 45, and 60 min after insulin injection. Cut-off analyses were performed using ROC curves.
Results
Twenty-five patients with AVD and 43 non-matched controls were available for analysis. Median basal copeptin concentrations of 1.51 pmol/L (IQR: 0.91–1.95; serum osmolarity: 288.5 mmol/L, IQR: 282.3–293.5) increased at a median of 30 min to a maximum of 1.95 pmol/L (IQR: 1.31–2.39) in AVD patients (p = 0.113) and from 4.41 pmol/L (IQR: 3.36–6.68; serum osmolarity: 281.0 mmol/L, IQR: 274.0–286.0, p < 0.001) to a maximum of 8.39 pmol/L (IQR: 4.95–19.72, p < 0.001) in controls. ROC analysis resulted in a cut-off of 3.0 pmol/L for maximum copeptin (91.7% sensitivity, 94.1% specificity) for the diagnosis of AVD.
Conclusion
Our results suggest that insulin-stimulated serum copeptin concentrations are a sensitive and specific diagnostic tool for AVD in paediatric patients, which allows us to test multiple pituitary hormone axes simultaneously in a single test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics I, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany, sebastian.gippert@med.uni-heidelberg.de.
- Division of Endocrinology, Diabetes, Metabolic Diseases and Clinical Chemistry, Central Laboratory, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
- Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics I, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
- Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics I, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany, markus.Bettendorf@med.uni-heidelberg.de.
Zitieren
APA
Gippert, S., Brune, M., Choukair, D., & Bettendorf, M. (2024). Insulin-Induced Copeptin Response in Children and Adolescents to Diagnose Arginine Vasopressin Deficiency. Hormone Research in Paediatrics. https://doi.org/10.1159/000541330
Vancouver
Gippert S, Brune M, Choukair D, Bettendorf M. Insulin-Induced Copeptin Response in Children and Adolescents to Diagnose Arginine Vasopressin Deficiency. Hormone Research in Paediatrics. 2024. doi:10.1159/000541330
BibTeX
@article{Gippert2024,
author = {Gippert, Sebastian and Brune, Maik and Choukair, Daniela and Bettendorf, Markus},
title = {Insulin-Induced Copeptin Response in Children and Adolescents to Diagnose Arginine Vasopressin Deficiency},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000541330}
}
EUVIMED